NACDS President and CEO Steven C. Anderson participated on May 30 in a panel discussion hosted by thINc360 – The Healthcare Innovation Congress in Washington, D.C. The panel, as part of the Food as Medicine Strategy Summit, was titled “Review Scalable Food as Medicine Innovations that Significantly Improve Health Outcomes and Mitigate Health Disparities,” and focused on how pharmacies and other healthcare stakeholders can help broaden the impact of food is medicine programs through technology, partnerships, and evidence-based interventions. The moderator for the panel was Holly Freishtat (pictured far left), Senior Director, Feeding Change, Milken Institute. Panelists (left to right) included Anderson; Denise Algire, Director of Health, Albertsons Companies; Judy Seybold, Co-Founder and Chief Nutrition Officer, Sifter; and Laura Allred, Director, Alliance Partnerships, Uber Health.
NACDS President and CEO Steven C. Anderson: “Consistent with a focus on health and wellness innovation, NACDS is proud to continue its ongoing commitment to driving food is medicine interventions and access. During the recent public health emergency, pharmacies and pharmacy teams proved their powerful reach — delivering nearly 350 million COVID-19 shots in a pharmacy setting and more than 42 million COVID-19 tests.
“Pharmacies are uniquely positioned to do even more to keep Americans healthy. Together with other healthcare providers and stakeholders, pharmacies have a vital role to play in scaling food is medicine programs, providing prevention and management services for chronic disease, and delivering total health and wellness solutions to the most vulnerable Americans. According to a Morning Consult poll commissioned by NACDS, 76% of adults in the U.S. support pharmacists helping patients to understand their nutritional choices and 73% support pharmacists helping patients prevent chronic disease such as heart disease and diabetes.”
RELATED CONTENT
